Bianco, G.; Boattini, M.; Comini, S.; Banche, G.; Cavallo, R.; Costa, C.
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine. Antibiotics 2023, 12, 604.
https://doi.org/10.3390/antibiotics12030604
AMA Style
Bianco G, Boattini M, Comini S, Banche G, Cavallo R, Costa C.
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine. Antibiotics. 2023; 12(3):604.
https://doi.org/10.3390/antibiotics12030604
Chicago/Turabian Style
Bianco, Gabriele, Matteo Boattini, Sara Comini, Giuliana Banche, Rossana Cavallo, and Cristina Costa.
2023. "Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine" Antibiotics 12, no. 3: 604.
https://doi.org/10.3390/antibiotics12030604
APA Style
Bianco, G., Boattini, M., Comini, S., Banche, G., Cavallo, R., & Costa, C.
(2023). Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine. Antibiotics, 12(3), 604.
https://doi.org/10.3390/antibiotics12030604
